Praxis Precision Medicines
PRAX
PRAX
149 hedge funds and large institutions have $1.31B invested in Praxis Precision Medicines in 2025 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 59 increasing their positions, 44 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
5% more funds holding
Funds holding: 142 → 149 (+7)
1.39% less ownership
Funds ownership: 118.57% → 117.18% (-1.4%)
50% less funds holding in top 10
Funds holding in top 10: 6 → 3 (-3)
Holders
149
Holding in Top 10
3
Calls
$27.3M
Puts
$22.7M
Top Buyers
| 1 | +$43M | |
| 2 | +$28.7M | |
| 3 | +$21.2M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$19.7M |
| 5 |
Goldman Sachs
New York
|
+$19.5M |
Top Sellers
| 1 | -$33.1M | |
| 2 | -$30.9M | |
| 3 | -$24.9M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$15.5M |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
-$13.2M |
